![](/imgs/covers/gm_cover.jpg)
|
European Journal of General Medicine
Medical Investigations Society
ISSN: 1304-3897
Vol. 1, No. 3, 2004, pp. 33-36
|
Bioline Code: gm04029
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
European Journal of General Medicine, Vol. 1, No. 3, 2004, pp. 33-36
en |
TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECTS: EXPERIENCE OF A PEDIATRIC HEART CENTER
Volkan Tuzcu, Ina Michel-Behnke, Dietmar Schranz
Abstract
Transcatheter closure of the ASDs has become the procedure of choice for most centers. In this article, we report our experience in 129 children who have undergone transcatheter closure of their ASDs. The balloon stretched diameter of the ASDs ranged between 6 and 28 mm. The immediate success rate for device closure was 92% and closure success rate was 98% at one year follow-up. There was no significant relationship between the ASD size and the initial-implant success rate (p =NS). Multifenestrated ASDs were present in 18% of patients. Significant complications, including device embolization, aortic root erosion, thrombus formation, and 1st degree AV block, occurred in 6% of patients. There were no procedure related deaths, and there were no residual adverse effects in patients who required removal of their devices. Transcatheter device closure of ASDs is an effective and safe procedure with elimination of intraatrial shunts in vast majority of patients, and this should be the procedure of choice for the closure of ASDs which are amenable to device closure.
Keywords
ASD, transcatheter closure
|
|
© Copyright 2004 - Medical Investigations Society Alternative site location: http://www.ejgm.org
|
|